Literature DB >> 12782565

Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction.

Jun-ichi Kotani1, Gary S Mintz, Marco T Castagna, Ellen Pinnow, Chalak O Berzingi, Anh B Bui, Augusto D Pichard, Lowell F Satler, William O Suddath, Ron Waksman, John R Laird, Kenneth M Kent, Neil J Weissman.   

Abstract

BACKGROUND: Previous studies have reported diffuse destabilization of atherosclerotic plaques in acute myocardial infarction (AMI). METHODS AND
RESULTS: We used intravascular ultrasound (IVUS) to assess 78 coronary arteries (38 infarct-related arteries [IRAs] with culprit and nonculprit lesions and 40 non-IRAs) from 38 consecutive AMI patients. IVUS analysis included qualitative and quantitative measurements of reference and lesion external elastic membrane (EEM), lumen, and plaque plus media (P&M) area. Positive remodeling was defined as lesion/mean reference EEM >1.0. Culprit lesions were identified by a combination of ECG, wall motion abnormalities (ventriculogram or echocardiogram), scintigraphic perfusion defects, and coronary angiogram. Culprit lesions contained more thrombus (23.7% versus 3.4% in nonculprit IRA plaques and 3.1% in non-IRA plaques; P=0.0011). Culprit lesions were predominantly hypoechoic (63.2% versus 37.9% of nonculprit IRA plaques and 28.1% of non-IRA plaques; P=0.0022). Culprit lesions were longer (17.5+/-10.1, 9.8+/-4.0, and 10.3+/-5.7 mm, respectively; P<0.0001), had larger EEM area (15.0+/-6.0, 11.5+/-5.7, and 12.6+/-5.6 mm2, respectively; P=0.0353) and P&M area (13.0+/-6.0, 7.5+/-3.7, 9.3+/-4.3 mm2, respectively; P<0.0001), smaller lumens (2.0+/-0.9, 4.1+/-3.1, and 3.4+/-2.5 mm2, respectively; P=0.0009), and more positive remodeling (79.4%, 59.0%, and 50.8%, respectively; P=0.0155). The frequency of plaque rupture/dissection was greater in culprit, nonculprit IRA, and non-IRA plaques in AMI patients than in a control group of chronic stable angina patients with multivessel IVUS imaging.
CONCLUSIONS: Culprit plaques have more markers of instability (thrombus, positive remodeling, and large plaque mass); however, these markers of instability are not typically found elsewhere. This suggests that the vascular event in AMI patients is determined by local pre-event lesion morphologies.

Entities:  

Mesh:

Year:  2003        PMID: 12782565     DOI: 10.1161/01.CIR.0000072768.80031.74

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

1.  Longitudinal heterogeneity of coronary artery distensibility in plaques related to acute coronary syndrome.

Authors:  Osamu Sasaki; Toshihiko Nishioka; Yoshiro Inoue; Ami Isshiki; Takashi Akima; Kentarou Toyama; Aki Koike; Toshiyuki Ando; Mikio Yuhara; Shun-ichi Sato; Tetsuo Kamiyama; Masato Kirimura; Hiroyuki Ito; Yoshiaki Maruyama; Nobuo Yoshimoto
Journal:  Clin Res Cardiol       Date:  2012-02-10       Impact factor: 5.460

2.  Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems.

Authors:  Yoshiki Matsuo; Takuro Takumi; Verghese Mathew; Woo-Young Chung; Gregory W Barsness; Charanjit S Rihal; Rajiv Gulati; Eric T McCue; David R Holmes; Eric Eeckhout; Ryan J Lennon; Lilach O Lerman; Amir Lerman
Journal:  Atherosclerosis       Date:  2012-05-31       Impact factor: 5.162

3.  Impact of arterial remodelling and plaque rupture on target and non-target lesion revascularisation after stent implantation in patients with acute coronary syndrome: an intravascular ultrasound study.

Authors:  Hiroyuki Okura; Haruyuki Taguchi; Tomoichiro Kubo; Iku Toda; Minoru Yoshiyama; Junichi Yoshikawa; Kiyoshi Yoshida
Journal:  Heart       Date:  2007-03-29       Impact factor: 5.994

4.  Differences in intravascular ultrasound and histological findings in culprit coronary plaques between ST-segment elevation myocardial infarction and stable angina.

Authors:  Cheol Whan Lee; Ilseon Hwang; Chan-Sik Park; Hyangsin Lee; Duk-Woo Park; Soo-Jin Kang; Seung-Whan Lee; Young-Hak Kim; Seong-Wook Park; Seung-Jung Park
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

Review 5.  Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance.

Authors:  Annamalai Senthilkumar; Maulik D Majmudar; Chetan Shenoy; Han W Kim; Raymond J Kim
Journal:  Heart Fail Clin       Date:  2009-07       Impact factor: 3.179

6.  [Clinical outcomes of intravascular ultrasound in guiding the treatment of non-left main intermediate coronary lesions for patients with acute coronary syndrome].

Authors:  Hong-Bin Liang; Qian Guo; Xin-Lu Zhang; Xue-Wei Liu; Yong-Zhen Tang; Wei-Yu Chen; Yu-Qing Hou; Jian-Cheng Xiu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

7.  High-grade culprit lesions are a common cause of ST-segment elevation myocardial infarction.

Authors:  Michael Liang; Takashi Kajiya; Mark Y Chan; Edgar Tay; Chi-Hang Lee; Arthur Mark Richards; Adrian F Low; Huay Cheem Tan
Journal:  Singapore Med J       Date:  2015-06       Impact factor: 1.858

8.  The distribution of calcified nodule and plaque rupture in patients with peripheral artery disease: an intravascular ultrasound analysis.

Authors:  Tetsuo Horimatsu; Kenichi Fujii; Masashi Fukunaga; Kojiro Miki; Machiko Nishimura; Yoshiro Naito; Masahiko Shibuya; Takahiro Imanaka; Kenji Kawai; Hiroto Tamaru; Akinori Sumiyoshi; Ten Saita; Tohru Masuyama; Masaharu Ishihara
Journal:  Heart Vessels       Date:  2017-05-02       Impact factor: 2.037

9.  Minor troponin T elevation in patients 6 months after acute myocardial infarction: an observational study.

Authors:  Mirja Neizel; Henning Steen; Grigorios Korosoglou; Dirk Lossnitzer; Stephanie Lehrke; Boris T Ivandic; Hugo A Katus; Evangelos Giannitsis
Journal:  Clin Res Cardiol       Date:  2009-03-12       Impact factor: 5.460

Review 10.  Intravascular ultrasound assessment of atherosclerosis.

Authors:  Antoine Guédès; Jean-Claude Tardif
Journal:  Curr Atheroscler Rep       Date:  2004-05       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.